lifornia, Florida, Europe,
Singapore, China, Japan, Korea and Taiwan. With over 20 years of continuous
innovation, March designs and manufactures a complete line of award-winning
and patented plasma processing systems. An expert staff of scientists and
engineers is available to assist in the design of plasma processes that
improve both product reliability and increase production yields. See the
March web site for more details:
http://www.marchplasma.com.
About Harland Medical Systems, Inc.:
Harland Medical Systems offers chemistries, process development
services, standard automation systems for applying and testing biosurfaces
and coating service capabilities to perform pilot and production medical
device coating. Harland Medical Systems has operations and application
laboratories in Eden Prairie and St. Paul, Minnesota and provides sales and
support on a worldwide basis.
For further information contact:
March Plasma Systems - World Headquarters
March Plasma Systems, Inc.
Dr. James Getty, Ph.D.
2470-A Bates Avenue
Concord, California 94520 U.S.A.
TEL: 925-827-1240
E-mail: info@marchplasma.com
Web: http://www.marchplasma.com
Harland Medical Systems, Inc.
Mr. Jon Anderson
7418 Washington Avenue South
Eden Prairie, MN 55344 U.S.A.
TEL: 952-941-0475
Web: http://harlandmedical.com
'/>"/>SOURCE March Plasma Systems Copyright©2008 PR Newswire. All rights reserved | |
Page: 1 2 Related biology technology :1.
Allos Therapeutics to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference2.
Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference to Webcast Alexzas Corporate Presentation3.
Cepheid Receives Health Canada Medical Device License for Xpert MRSA(TM) Test and GeneXpert(R) System4.
Advanced Medical Specialties Joins US Oncology Network5.
Sharps Compliance Corp. Announces Purchase of Medical Waste Disposal Facility and Addition of Autoclave Technology6.
VNUS Medical Technologies to Report Fourth-Quarter 2007 Results and Webcast Teleconference on February 77.
Angiotech and Symphony Medical Announce Licensing Agreement8.
Stereotaxis Appoints David Burkhardt, M.D. as Chief Medical Officer9.
CNS Response, Inc Completes Neuro-Therapy Clinic Acquisition; Names Daniel A. Hoffman, MD Chief Medical Officer10.
Five Medical Technology Companies Host Premier Event for Cardiothoracic Surgeons11.
Bookham to Enter Biomedical Illumination Market